Healthcare R&D 500

  • ID: 4451060
  • Report
  • 133 pages
  • FinGlobe, Inc
1 of 3

The healthcare sector is spending an increasing amount on medical and health research and development. With most of the healthcare companies engaged substantially and continuously in R&D, a ranking can provide a clearer picture of their comparative R&D performance. This report offered provides such rankings of leading global healthcare companies based on their research and development focus that will enable investors, analysts, regulators, and market competitors to identify the top R&D intensive healthcare companies worldwide.

Key Features of the report:

  • 1,000 global healthcare companies comprehensively analyzed to identify top global 500 R&D intensive companies
  • Ranking methodology objective and purely R&D-based
  • Selected top global 500 R&D intensive companies analyzed by region and country, sub-industry, and market capitalization group; as well as from various other perspectives
  • Selected R&D 500 companies segregated into various modules of 100 companies each
  • Rankings based on R&D expenses, R&D expenses as % of total sales and R&D growth assigned to 100 companies includedin each module
  • Rankings based on recent four quarters’ data
  • Rankings presented by ranks, region and country, and sub-industry
  • 100 companies includedin each module also analyzed from various other perspectives

Report useful to:

  • Investors looking for emerging investing opportunities
  • Analysts in search of healthy portfolios
  • Healthcare firms seeking new partners for collaborations
  • Healthcare executives assessing their competitors’ R&D growth
  • Service providers to identify new business opportunities
  • Market competitors to identify leading R&D intensive firms
READ MORE
Note: Product cover images may vary from those shown
2 of 3

Research Methodology

Chapter 1: Identification of 500 Companies from Healthcare R&D Input Dataset

1.1: Frequency Charts of R&D 500 Companies in Healthcare Sector
1.1a By region and country
1.1b By sub-industry within healthcare sector
1.1c By market capitalization group

1.2: Top Down R&D 500 Companies in Healthcare Sector
1.2a By R&D expenses of latest quarter
1.2b By region, country, and R&D expenses
1.2c By sub-industry within healthcare sector and R&D expenses
1.2d By market capitalization group and R&D expenses

Chapter 2: Analysis of R&D 500 Companies in Healthcare Sector

2.1: Major 25 gainers and decliners in R&D in Q4 vs. Q3
2.2: Companies dropped from and added to R&D 500 in Q4
2.3: Consistency in growth in R&D during Q4 to Q1
2.4: Peer analysis for R&D investment

2.5: R&D investment from emerging market companies
2.6: R&D investment by smaller companies
2.7: R&D news vs. R&D ranks

Chapter 3: Summary and Conclusions

Appendices

Appendix 1: List of R&D 500 companies in healthcare sector: By region, country and company name
Appendix 2: List of R&D 500 companies in healthcare sector: By sub-industry, country and company name
Appendix 3: List of non-listed 50 companies in healthcare sector active in R&D news
Appendix 4: List of non-listed 50 companies in healthcare sector active in business news
Appendix 5: List of top 50 among R&D 500 companies where Q4 data not available but Q3 data available

Appendix 6: List of next 100 companies in healthcare sector beyond R&D 500 companies
Appendix 7: List of Biotech companies not disclosing R&D expenses
Appendix 8: List of Medical Devices companies not disclosing R&D expenses
Appendix 9: List of Pharmaceuticals companies not disclosing R&D expenses

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll